GlassScriptPhysician profile
Garren J Decaro
NPI 1326381682
$1,665.05
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,414 · 2020: $33.32 · 2021: $79.56 · 2022: $138.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $247.14 | 2019-2022 | |
| Amgen INC. | $238.36 | 2019 | |
| Pfizer INC. | $192.61 | 2019 | |
| Lilly USA, LLC | $181.90 | 2019 | |
| Novo Nordisk INC | $130.57 | 2019 | |
| Merck Sharp & Dohme LLC | $122.51 | 2019 | |
| Novartis Pharmaceuticals Corporation | $94.07 | 2019-2022 | |
| Amarin Pharma, INC. | $87.99 | 2019-2022 | |
| Allergan, INC. | $80.84 | 2019 | |
| Scilex Pharmaceuticals INC. | $56.56 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.08 | 2019-2022 | |
| Astellas Pharma US INC | $36.46 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $35.99 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.10 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.63 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $14.42 | 2019 | |
| Horizon Therapeutics Plc | $13.95 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.79 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.66 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.42 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garren Decaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.